Heron Therapeutics, Inc. (HRTX)
0.3181
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
0.3181
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Total Liabilities (Quarterly) : 245.35M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 245.35M |
| March 31, 2026 | 237.08M |
| December 31, 2025 | 656.54M |
| September 30, 2025 | 234.06M |
| June 30, 2025 | 259.35M |
| March 31, 2025 | 264.20M |
| December 31, 2024 | 266.80M |
| September 30, 2024 | 260.78M |
| June 30, 2024 | 256.08M |
| March 31, 2024 | 251.65M |
| December 31, 2023 | 256.48M |
| September 30, 2023 | 256.98M |
| June 30, 2023 | 240.51M |
| March 31, 2023 | 232.31M |
| December 31, 2022 | 237.38M |
| September 30, 2022 | 249.50M |
| June 30, 2022 | 265.70M |
| March 31, 2022 | 249.76M |
| December 31, 2021 | 228.14M |
| September 30, 2021 | 233.54M |
| June 30, 2021 | 244.14M |
| March 31, 2021 | 114.71M |
| December 31, 2020 | 117.06M |
| September 30, 2020 | 112.88M |
| June 30, 2020 | 108.66M |
| Date | Value |
|---|---|
| March 31, 2020 | 113.47M |
| December 31, 2019 | 108.95M |
| September 30, 2019 | 107.52M |
| June 30, 2019 | 106.31M |
| March 31, 2019 | 103.98M |
| December 31, 2018 | 92.02M |
| September 30, 2018 | 64.09M |
| June 30, 2018 | 78.66M |
| March 31, 2018 | 91.18M |
| December 31, 2017 | 103.17M |
| September 30, 2017 | 78.14M |
| June 30, 2017 | 73.30M |
| March 31, 2017 | 87.40M |
| December 31, 2016 | 88.73M |
| September 30, 2016 | 80.93M |
| June 30, 2016 | 27.89M |
| March 31, 2016 | 19.17M |
| December 31, 2015 | 19.74M |
| September 30, 2015 | 16.45M |
| June 30, 2015 | 16.59M |
| March 31, 2015 | 11.63M |
| December 31, 2014 | 13.62M |
| September 30, 2014 | 11.27M |
| June 30, 2014 | 10.79M |
| March 31, 2014 | 7.384M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Praxis Precision Medicines, Inc. | 49.06M |
| Tonix Pharmaceuticals Holding Corp. | 31.81M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 252.26M |
| Shareholders Equity (Quarterly) | 6.908M |
| Debt to Equity Ratio | 21.48 |
| Current Ratio | 2.494 |
| Net Debt Paydown Yield | 7.15% |